Stocks in the News — week of March 24, 2014 (March 27th update)

Baxter International to Separate into Two Healthcare Companies in Mid-2015

(BAX, $73.93, up $3.85 midday)

Baxter International announced today that it will spin off its biopharmaceutical business to shareholders in mid-2015.  The remaining company will focus on life-saving medical products.  Read more from MarketWatch.

BAX has not earned a buy rating at Goodfellow LLC because earnings growth is not strong enough to meet my investment criteria.  Earnings per share (EPS) are expected to grow 10%, 7%, and 8% in 2014 through 2016 (December year-end).  The dividend yield is 2.64%, and the price-earnings ratio (PE) is 14.4, within a normal range of 12-27.  The 2013 long-term debt ratio was 47%.

The stock reached all-time highs today on the spin-off news.  I would not chase the stock here, because the market will become bored with the spin-off news by the weekend, and the stock will likely have a pullback.

I owned shares of BAX until this morning.  I bought them in December, after the Fall 2013 market correction, in order to catch the rebound and the dividend.  I had a sell limit order in place at the top of the trading range, and was pleased to see the stock sell higher than the limit, at $75.10, at the open of trading today.

Current shareholders who are more focused on capital gains than on a long-term buy-and-hold strategy should sell now.  Re-deploy the principal into a stock with strong earnings growth and a bullish chart.  Subscribe now for excellent ideas to improve your portfolio performance!

Goodfellow LLC rating: Sell, Public.  (03-27-14)

BAX Chart

BAX data by YCharts

* * * * *

Hewlett-Packard Shares Continue Rising

Shares of computer products company Hewlett-Packard (HPQ, $32.35) continue to climb since I told investors about the price breakout on March 18.  At that time I said, “Sometimes it’s very obvious from technical charts to predict what the stock is likely to do next.  In that light, I believe that HPQ is breaking past medium-term price resistance.  Shareholders should hold their stock for additional gains, and use stop-loss orders to protect their downside.  Experienced momentum investors could jump in here for near-term capital gains.”

Hewlett-Packard shares are up 29% since my “trading buy” recommendation on November 26, and 45% since my August 22 buy recommendation on Ransom Notes Radio.

I think the stock can rise to at least $35 in the near-term before having a pullback.

Subscribe to Goodfellow LLC now for profitable stock ideas, screened via fundamental and technical analysis in order to minimize risk.

Goodfellow LLC Rating:  Hold, Value, Volatile, Public.  (03-26-14)

HPQ Chart

HPQ data by YCharts

* * * * *

Facebook Shares Fall on News of Oculus Purchase

(FB, $60.89, down $4.00 midday)

Facebook Inc. announced plans to purchase Oculus VR, a leader in immersive virtual reality technology, for future use in gaming, communications, and commerce.  Facebook CEO Mark Zuckerberg sees augmented reality as the next big phase in technology.

Facebook will pay up to $2.3 billion for Oculus, through a combination of $400 million cash, $1.6 billion stock, and $300 million in earnouts.  The deal will close in the second quarter of 2014.

I last wrote about FB shares on March 10, when I successfully advised investors to complete a trading buy recommendation from January 30.  The stock reached its highest closing price that day, at which point I changed the rating to hold, saying, “The stock is overvalued.”

While there is no material change in the strong earnings growth outlook today, the price-earnings ratio (PE), which was already quite high, will necessarily jump higher when the new shares are issued for the Oculus purchase.

FB’s share price has now lost all its gains since my January 30 buy recommendation, and I hope that Goodfellow LLC subscribers heeded my warning on March 10 to use stop-loss orders.

Goodfellow LLC RatingAggressive Growth, Volatile, Public.  (03-26-14)

FB Chart

FB data by YCharts

 

* * * * *

AOL Shares Up 5% on Analyst Report

(AOL, $44.50, up $2.25 midday)

The Fly on the Wall reported today, “Jefferies reiterates a Buy rating on AOL following recent weakness in the stock and says the company’s Network segment is an underappreciated longer term opportunity. The firm says AOL remains a favorite mid-cap name and it keeps a $66 price target for shares.”

Time Warner (TWX) spun off internet services company AOL Inc. into a separately traded public company in December 2009.  AOL’s earnings per share (EPS) are expected to grow 8%, 18% and 14% in 2014 through 2016 (December year-end).  The price-earnings ratio (PE) is high at 19.8.

AOL shares traded sideways for twelve months through November 2013, then broke through upside resistance.  The price peaked in mid-January, and has been ratcheting downward ever since.

I wouldn’t go bottom-fishing here, but would rather concentrate on undervalued stocks with strong earnings growth projections and bullish charts.  If somebody gave me the stock today, I’d put in a sell order at $45, then move on.

Subscribe now for buy-rated stock ideas from Goodfellow LLC!

Goodfellow LLC Rating:  Sell, Public.  (03/26/14)

AOL Chart

AOL data by YCharts

* * * * *

Gilead Favored in Court Ruling; Frowned Upon in Congress

(GILD, $71.49, down $0.58 midday)

I wrote about Gilead Sciences on March 14.  Since then, there have been changes in news, and in stock price.

A Norwegian court has ruled against Idenix Pharmaceuticals in a patent case vs. Gilead Sciences.  MarketWatch says that Idenix will appeal the ruling.

And in the U.S., lawmakers in the House Energy & Commerce Committee are questioning Gilead Sciences over the $84,000 annual cost of its new hepatitis C drug.  “While the treatment has been shown to cure many patients, the payors are balking at the prospect of covering the therapy for millions of people at a cost in the billions of dollars,” reports Reuters.

Subscribe now to read about Gilead’s earnings projections, technical chart analysis, and my buy/hold/sell recommendation.

* * * * *

Earnings per share (EPS) growth at AT&T Inc., rapid in recent years, has slowed dramatically to an expected 4-6% per year in 2014 through 2016.  The dividend is large at 5.3%; and the PE is high at 13.1.

I think that the stock can rise to $35 in the near-term, then it will likely continue to trade sideways.  With earnings growth projections falling, I would trade out of this overvalued stock at $35 and move on to a company with strong earnings growth and a bullish chart.

Goodfellow LLC rating:  Sell, Public.  (03-24-14)

T Chart

T data by YCharts

* * * * *

Send questions and comments to research@GoodfellowLLC.com.

Happy investing!

Crista Huff

President

Goodfellow LLC

* * * *

Investment Disclaimer Release of Liability: Through use of this website viewing or using you agree to hold www.GoodfellowLLC.com and its employees harmless and to completely release www.GoodfellowLLC.com and its employees from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Goodfellow LLC and its employees are not paid by third parties to promote nor disparage any investment.

Recommendations are based on hypothetical situations of what we would do, not advice on what you should do. Neither Goodfellow LLC nor its employees are licensed investment advisors, tax advisors, nor attorneys. Consult with a licensed investment advisor and a tax advisor to determine the suitability of any investment.

The information provided herein is obtained from sources believed to be reliable but is not guaranteed as to accuracy or completeness. When information is provided herein from third parties — such as financial news outlets, financial websites, investment firms, or any other source of financial information – the reliability or completeness of such financial information cannot be guaranteed. The information contained on this website is provided for informational purposes only and contains no investment advice or recommendations to buy or sell any specific securities.

This is not an offer or solicitation for any particular trading strategy, or confirmation of any transaction. Statements made on the website are based on the authors’ opinions and based on information available at the time this page was published. The creators are not liable for any errors, omissions or misstatements. Any performance data quoted represents past performance and past performance is not a guarantee of future results.

Investments always have a degree of risk, including the potential risk of the loss of the investor’s entire principal. There is no guarantee against any loss.

* * * *
Goodfellow LLC is a subscription-only stock market website. We strive to identify financially healthy companies in which traders and investors can buy shares and earn dividends and capital gains. See disclaimer for the risks associated with investing in the stock market. See your tax advisor for the tax consequences of investing. See your estate planning attorney to clarify beneficiary and inheritance issues associated with your assets.

 

Leave a Reply

Your email address will not be published. Required fields are marked *